Ultrasound-fluoroscopy registration for prostate brachytherapy dosimetry - Abstract

Prostate brachytherapy is a treatment for prostate cancer using radioactive seeds that are permanently implanted in the prostate.

The treatment success depends on adequate coverage of the target gland with a therapeutic dose, while sparing the surrounding tissue. Since seed implantation is performed under transrectal ultrasound (TRUS) imaging, intraoperative localization of the seeds in ultrasound can provide physicians with dynamic dose assessment and plan modification. However, since all the seeds cannot be seen in the ultrasound images, registration between ultrasound and fluoroscopy is a practical solution for intraoperative dosimetry. In this manuscript, we introduce a new image-based nonrigid registration method that obviates the need for manual seed segmentation in TRUS images and compensates for the prostate displacement and deformation due to TRUS probe pressure. First, we filter the ultrasound images for subsequent registration using thresholding and Gaussian blurring. Second, a computationally efficient point-to-volume similarity metric, an affine transformation and an evolutionary optimizer are used in the registration loop. A phantom study showed final registration errors of 0.84±0.45mm compared to ground truth. In a study on data from 10 patients, the registration algorithm showed overall seed-to-seed errors of 1.7±1.0mm and 1.5±0.9mm for rigid and nonrigid registration methods, respectively, performed in approximately 30s per patient.

Written by:
Dehghan E, Lee J, Fallavollita P, Kuo N, Deguet A, Le Y, Clif Burdette E, Song DY, Prince JL, Fichtinger G.   Are you the author?
Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD, USA; School of Computing, Queen's University, Kingston, ON, Canada.

Reference: Med Image Anal. 2012 Jun 16. Epub ahead of print.
doi: 10.1016/j.media.2012.06.001

PubMed Abstract
PMID: 22784870

UroToday.com Prostate Cancer Section